Literature DB >> 14679174

It takes two to tango: mast cell and Schwann cell interactions in neurofibromas.

David H Viskochil1.   

Abstract

Neurofibromas are benign tumors comprised primarily of Schwann cells and fibroblasts. Mast cell infiltration is a well-known phenomenon; however, their role in tumor pathogenesis has been enigmatic. In an elegant set of experiments using cells derived from a murine model of neurofibromatosis 1 (NF1), Yang et al. dissect the molecular pathways involved in mast cell migration to neurofibromin-deficient Schwann cells. These results set the stage for rational development of therapeutics that could influence the multicellular microenvironment of neurofibromas to inhibit the development and/or progression of these tumors in human NF1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14679174      PMCID: PMC297005          DOI: 10.1172/JCI20503

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Mast cells--their presence and ultrastructural characteristics in peripheral nerve tumors.

Authors:  A Pineda
Journal:  Arch Neurol       Date:  1965-10

2.  A novel cell-to-cell interaction between mast cells and other cell types.

Authors:  G Greenberg; G Burnstock
Journal:  Exp Cell Res       Date:  1983-08       Impact factor: 3.905

3.  Mast cells in human peripheral nerve.

Authors:  Y Olsson
Journal:  Acta Neurol Scand       Date:  1971       Impact factor: 3.209

4.  Multiple cell origin of hereditary neurofibromas.

Authors:  P J Fialkow; R W Sagebiel; S M Gartler; D L Rimoin
Journal:  N Engl J Med       Date:  1971-02-11       Impact factor: 91.245

5.  Mast-cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen.

Authors:  V M Riccardi
Journal:  Arch Dermatol       Date:  1987-08

6.  Neurofibromas in NF1: Schwann cell origin and role of tumor environment.

Authors:  Yuan Zhu; Pritam Ghosh; Patrick Charnay; Dennis K Burns; Luis F Parada
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

7.  Mast cell and lymphoreticular infiltrates in neurofibromas. Comparison with nerve sheath tumors.

Authors:  M D Johnson; J Kamso-Pratt; C F Federspiel; W O Whetsell
Journal:  Arch Pathol Lab Med       Date:  1989-11       Impact factor: 5.534

8.  Mast cells in benign nerve sheath tumours.

Authors:  P Isaacson
Journal:  J Pathol       Date:  1976-08       Impact factor: 7.996

Review 9.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

10.  Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells.

Authors:  V M Riccardi
Journal:  Birth Defects Orig Artic Ser       Date:  1981
View more
  10 in total

1.  Occipital peripheral nerve stimulation in the management of chronic intractable occipital neuralgia in a patient with neurofibromatosis type 1: a case report.

Authors:  Ioannis Skaribas; Octavio Calvillo; Evangelia Delikanaki-Skaribas
Journal:  J Med Case Rep       Date:  2011-05-10

2.  PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors.

Authors:  Vincent W Keng; Eric P Rahrmann; Adrienne L Watson; Barbara R Tschida; Christopher L Moertel; Walter J Jessen; Tilat A Rizvi; Margaret H Collins; Nancy Ratner; David A Largaespada
Journal:  Cancer Res       Date:  2012-06-14       Impact factor: 12.701

3.  The plexiform neurofibroma microenvironment.

Authors:  Feng-Chun Yang; Karl Staser; D Wade Clapp
Journal:  Cancer Microenviron       Date:  2012-07-24

4.  Midline cutaneous lumbosacral lesions: not always a sign of occult spinal dysraphism.

Authors:  Juan F Martínez-Lage; Belen Ferri Niguez; Miguel A Pérez-Espejo; María J Almagro; Concepción Maeztu
Journal:  Childs Nerv Syst       Date:  2006-02-01       Impact factor: 1.475

5.  Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.

Authors:  Andrew S McDaniel; Jayme D Allen; Su-Jung Park; Zahara M Jaffer; Elizabeth G Michels; Sarah J Burgin; Shi Chen; Waylan K Bessler; Clemens Hofmann; David A Ingram; Jonathan Chernoff; D Wade Clapp
Journal:  Blood       Date:  2008-09-02       Impact factor: 22.113

6.  Neuro-oncology of Neurofibromatosis Type 1.

Authors:  Andreas F Hottinger; Yasmin Khakoo
Journal:  Curr Treat Options Neurol       Date:  2009-07       Impact factor: 3.598

7.  Ulcerative colitis and neurofibromatosis type 1 with bilateral psoas muscle neurofibromas: a case report.

Authors:  Hamid Tavakkoli; Mehrnaz Asadi; Parvin Mahzouni; Abdolali Foroozmehr
Journal:  J Res Med Sci       Date:  2009-07       Impact factor: 1.852

8.  Solitary fibrous tumor of the oral cavity: clinicopathologic and immunohistochemical study of 21 cases.

Authors:  Esther M O'Regan; Vijay Vanguri; Carl M Allen; Lewis Roy Eversole; John M Wright; Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2009-04-28

9.  Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNST.

Authors:  Vincent W Keng; Adrienne L Watson; Eric P Rahrmann; Hua Li; Barbara R Tschida; Branden S Moriarity; Kwangmin Choi; Tilat A Rizvi; Margaret H Collins; Margaret R Wallace; Nancy Ratner; David A Largaespada
Journal:  Sarcoma       Date:  2012-12-18

Review 10.  Cutaneous neurofibromas in the genomics era: current understanding and open questions.

Authors:  Robert J Allaway; Sara J C Gosline; Salvatore La Rosa; Pamela Knight; Annette Bakker; Justin Guinney; Lu Q Le
Journal:  Br J Cancer       Date:  2018-04-26       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.